InsightfulValue
← Home

Pfizer
Pfizer

-12.34%

Pharma / Pharmaceuticals and biotechnology


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

Pfizer

πŸ“Š Get full analytics about Pfizer

Sign up for free or log in

⚑ Instantly access "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

Price
Live  
Infographic
Infographics
Overview
Pfizer, Inc. is a multinational pharmaceutical company founded in 1849 by Charles Pfizer and Charles Erhart in Brooklyn, New York. The company is currently headquartered in New York City and operates in over 175 countries around the world.
Pfizer is known for its innovations in medicine, and has developed multiple blockbuster drugs, including Viagra, Lipitor, and Celebrex. The company has a diverse portfolio of prescription medicines, vaccines, and consumer healthcare products.
Pfizer works to improve global health by providing access to quality healthcare, increasing access to medicines, and investing in medical research and development. The company also partners with organizations and governments to address public health challenges, such as addressing infectious diseases and expanding access to healthcare in emerging markets.
In addition to its focus on healthcare and pharmaceuticals, Pfizer has a strong commitment to corporate responsibility and sustainability. The company aims to reduce its environmental impact, promote diversity and inclusion, and support community outreach initiatives.
Overall, Pfizer's mission is to discover, develop, and provide innovative medicines and vaccines that improve the lives of people around the world.
How to explain to a 10 year old kid about the company?
Pfizer

πŸ“ˆ Want to read more about Pfizer?

Sign up for free or log in

πŸ†“ Discover "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free eBook!

UGZpemVyIG lzIGEgYmln IGNvbXBhbn kgdGhhdCBt YWtlcyBtZW RpY2luZXMg YW5kIHZhY2 NpbmVzIHRv IGhlbHAgcG VvcGxlIGZl ZWwgYmV0dG VyIGFuZCBz dGF5IGhlYW x0aHkuIFRo aW5rIG9mIH RoZW0gbGlr ZSBhIHN1cG VyaGVybyBm b3Igb3VyIG hlYWx0aC4g V2hlbiBwZW 9wbGUgZ2V0 IHNpY2sgb3 IgbmVlZCBt ZWRpY2luZS B0byBwcmV2 ZW50IGdldH Rpbmcgc2lj aywgZG9jdG 9ycyBvZnRl biB1c2UgdG hpbmdzIHRo YXQgUGZpem VyIGhhcyBj cmVhdGVkLj xicj5Tbywg aG93IGRvZX MgUGZpemVy IG1ha2UgbW 9uZXk/IFdo ZW4gZG9jdG 9ycyBnaXZl IHRoZWlyIH BhdGllbnRz IHRoZXNlIG 1lZGljaW5l cyBhbmQgdm FjY2luZXMs IGhvc3BpdG FscyBhbmQg cGhhcm1hY2 llcyBidXkg dGhlbSBmcm 9tIFBmaXpl ci4gVGhlIG NvbXBhbmll cyB0aGVuIH NlbGwgdGhv c2UgbWVkaW NpbmVzIHRv IHBlb3BsZS wgYW5kIHRo YXTigJlzIG hvdyBQZml6 ZXIgZWFybn MgbW9uZXku IFRoZXkgYW xzbyBnZXQg bW9uZXkgd2 hlbiB0aGV5 IGNyZWF0ZS BuZXcgbWVk aWNpbmVzIG FuZCBzZWxs IHRoZW0gdG 8gb3RoZXIg Y291bnRyaW VzIGFyb3Vu ZCB0aGUgd2 9ybGQuPGJy PlBmaXplci BpcyBzdWNj ZXNzZnVsIG ZvciBhIGZl dyByZWFzb2 5zLiBGaXJz dCwgdGhleS BzcGVuZCBh IGxvdCBvZi B0aW1lIGFu ZCBtb25leS BtYWtpbmcg c3VyZSB0aG VpciBtZWRp Y2luZXMgYX JlIGJvdGgg c2FmZSBhbm QgZWZmZWN0 aXZlIGJlZm 9yZSB0aGV5 IGNhbiBzZW xsIHRoZW0u IFRoaXMgZ2 l2ZXMgcGVv cGxlIGFuZC Bkb2N0b3Jz IGNvbmZpZG VuY2UgaW4g dGhlaXIgcH JvZHVjdHMu IFNlY29uZC wgUGZpemVy IGlzIGFsd2 F5cyB3b3Jr aW5nIG9uIG 5ldyBtZWRp Y2luZXMgYW 5kIHZhY2Np bmVzLCB3aG ljaCBtZWFu cyB0aGV5IG FyZSBhbHdh eXMgbG9va2 luZyBmb3Ig d2F5cyB0by BoZWxwIGV2 ZW4gbW9yZS BwZW9wbGUu IEZvciBleG FtcGxlLCB0 aGV5IGhlbH BlZCBtYWtl IGEgQ09WSU QtMTkgdmFj Y2luZSB0aG F0IG1hbnkg cGVvcGxlIG dvdCB0byBw cm90ZWN0IH RoZW1zZWx2 ZXMgZnJvbS B0aGUgdmly dXMuPGJyPk luIHRoZSBm dXR1cmUsIF BmaXplciB3 aWxsIGxpa2 VseSBjb250 aW51ZSB0by BiZSBzdWNj ZXNzZnVsIG JlY2F1c2Ug dGhlcmUgd2 lsbCBhbHdh eXMgYmUgYS BuZWVkIGZv ciBuZXcgbW VkaWNpbmVz IGFuZCB2YW NjaW5lcy4g UGVvcGxlIH dpbGwgYWx3 YXlzIGdldC BzaWNrIGFu ZCBuZWVkIG hlbHAsIGFu ZCBzY2llbn Rpc3RzIGFy ZSBhbHdheX MgZGlzY292 ZXJpbmcgbm V3IHRoaW5n cyBhYm91dC BoZWFsdGgs IHdoaWNoIG 1lYW5zIG1v cmUgb3Bwb3 J0dW5pdGll cyBmb3IgUG ZpemVyIHRv IGhlbHAuIF RoZXkgaGF2 ZSBhIGdvb2 QgdGVhbSBv ZiBzY2llbn Rpc3RzIGFu ZCByZXNlYX JjaGVycyB3 aG8ga2VlcC BjcmVhdGlu ZyBtb3JlIH dheXMgdG8g aGVscCBwZW 9wbGUsIHdo aWNoIGlzIH doeSB0aGV5 IHdpbGwgcH JvYmFibHkg a2VlcCBiZW luZyBzdWNj ZXNzZnVsIG ZvciBtYW55 IHllYXJzIH RvIGNvbWUu PGJyPg==
What is special about the company?
Pfizer

πŸ“ˆ Want to read more about Pfizer?

Sign up for free or log in

✍️ Sign up to get "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" for free

MS4gUGlvbm VlciBpbiB0 aGUgcGhhcm 1hY2V1dGlj YWwgaW5kdX N0cnk6IFBm aXplciBpcy BvbmUgb2Yg dGhlIHdvcm xkJ3Mgb2xk ZXN0IGFuZC BsYXJnZXN0 IHBoYXJtYW NldXRpY2Fs IGNvbXBhbm llcywgZXN0 YWJsaXNoZW QgaW4gMTg0 OS4gSXQgaG FzIGEgbG9u ZyBoaXN0b3 J5IG9mIGRl dmVsb3Bpbm cgYW5kIG1h bnVmYWN0dX JpbmcgaW5u b3ZhdGl2ZS BtZWRpY2lu ZXMsIG1ha2 luZyBpdCBh IHRydXN0ZW QgYnJhbmQg aW4gdGhlIG dsb2JhbCBo ZWFsdGhjYX JlIGluZHVz dHJ5Ljxicj 4yLiBTdHJv bmcgcmVzZW FyY2ggYW5k IGRldmVsb3 BtZW50OiBQ Zml6ZXIgaG FzIGEgcm9i dXN0IHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudCBw cm9ncmFtLC BpbnZlc3Rp bmcgYmlsbG lvbnMgb2Yg ZG9sbGFycy Bhbm51YWxs eSBpbiB0aG UgZGV2ZWxv cG1lbnQgb2 YgbmV3IG1l ZGljaW5lcy BhbmQgdHJl YXRtZW50cy 4gSXRzIHRl YW0gb2Ygc2 NpZW50aXN0 cywgcmVzZW FyY2hlcnMs IGFuZCBjbG luaWNpYW5z IHdvcmsgdG 9nZXRoZXIg dG8gc29sdm Ugc29tZSBv ZiB0aGUgbW 9zdCBzaWdu aWZpY2FudC BoZWFsdGhj YXJlIGNoYW xsZW5nZXMg YW5kIGltcH JvdmUgcGF0 aWVudCBvdX Rjb21lcy48 YnI+My4gR2 xvYmFsIHBy ZXNlbmNlOi BQZml6ZXIg aGFzIGEgc3 Ryb25nIGds b2JhbCBwcm VzZW5jZSwg d2l0aCBvcG VyYXRpb25z IGluIG92ZX IgMTc1IGNv dW50cmllcy BhbmQgdGVy cml0b3JpZX Mgd29ybGR3 aWRlLiBJdC BoYXMgYSBk aXZlcnNpZm llZCBwb3J0 Zm9saW8gb2 YgcHJvZHVj dHMgYW5kIH NlcnZlcyBh IGJyb2FkIH JhbmdlIG9m IHRoZXJhcG V1dGljIGFy ZWFzLCBpbm NsdWRpbmcg aW5mZWN0aW 91cyBkaXNl YXNlcywgb2 5jb2xvZ3ks IHJhcmUgZG lzZWFzZXMs IGFuZCBjYX JkaW92YXNj dWxhciBkaX NvcmRlcnMu PGJyPjQuIE ZvY3VzIG9u IGlubm92YX Rpb246IFdp dGggYSBkZW RpY2F0ZWQg YW5kIGhpZ2 hseSBza2ls bGVkIHRlYW 0gb2Ygc2Np ZW50aXN0cy BhbmQgcmVz ZWFyY2hlcn MsIFBmaXpl ciBjb250aW 51ZXMgdG8g aW5ub3ZhdG UgYW5kIGRl dmVsb3Agbm V3IHRyZWF0 bWVudHMgZm 9yIHVubWV0 IG1lZGljYW wgbmVlZHMu IEl0IGhvbG RzIG51bWVy b3VzIHBhdG VudHMgYW5k IGhhcyBzZX ZlcmFsIHN1 Y2Nlc3NmdW wgcHJvZHVj dHMsIHN1Y2 ggYXMgVmlh Z3JhLCBMaX BpdG9yLCBh bmQgUHJldm 5hci48YnI+ NS4gQ29tbW l0bWVudCB0 byBxdWFsaX R5IGFuZCBz YWZldHk6IF BmaXplciBo YXMgYSBzdH JpY3QgcXVh bGl0eSBjb2 50cm9sIHN5 c3RlbSBpbi BwbGFjZSB0 byBlbnN1cm UgdGhlIHNh ZmV0eSBhbm QgZWZmaWNh Y3kgb2YgaX RzIHByb2R1 Y3RzLiBJdC Bmb2xsb3dz IHN0cmljdC BtYW51ZmFj dHVyaW5nIH N0YW5kYXJk cyBhbmQgcm VndWxhdGlv bnMgaW4gYW xsIGl0cyBm YWNpbGl0aW VzIHdvcmxk d2lkZSB0by BkZWxpdmVy IHNhZmUgYW 5kIGVmZmVj dGl2ZSBtZW RpY2luZXMg dG8gcGF0aW VudHMuPGJy PjYuIFNvY2 lhbCByZXNw b25zaWJpbG l0eTogUGZp emVyIGlzIG NvbW1pdHRl ZCB0byBtYW tpbmcgYSBw b3NpdGl2ZS BpbXBhY3Qg b24gdGhlIG NvbW11bml0 aWVzIGl0IH NlcnZlcy4g VGhyb3VnaC BpdHMgY29y cG9yYXRlIH NvY2lhbCBy ZXNwb25zaW JpbGl0eSBp bml0aWF0aX ZlcywgdGhl IGNvbXBhbn kgc3VwcG9y dHMgdmFyaW 91cyBoZWFs dGhjYXJlIH Byb2dyYW1z LCBlZHVjYX Rpb24sIGFu ZCBlbnZpcm 9ubWVudGFs IHN1c3RhaW 5hYmlsaXR5 IGVmZm9ydH MuPGJyPjcu IFN0cm9uZy BmaW5hbmNp YWwgcGVyZm 9ybWFuY2U6 IFBmaXplci BpcyBhIGZp bmFuY2lhbG x5IHN0YWJs ZSBjb21wYW 55IHdpdGgg YSBzdHJvbm cgdHJhY2sg cmVjb3JkIG 9mIGdyb3d0 aCBhbmQgcH JvZml0YWJp bGl0eS4gSX RzIGZpbmFu Y2lhbCBzdG FiaWxpdHkg YW5kIHBlcm Zvcm1hbmNl IGFyZSByZW ZsZWN0ZWQg aW4gY29uc2 lzdGVudGx5 IGhpZ2ggc3 RvY2sgcHJp Y2VzIGFuZC BjcmVkaXQg cmF0aW5ncy 48YnI+OC4g SW5ub3ZhdG l2ZSBwYXJ0 bmVyc2hpcH M6IFBmaXpl ciBoYXMgcG FydG5lcmVk IHdpdGggb3 RoZXIgbGVh ZGluZyBwaG FybWFjZXV0 aWNhbCBjb2 1wYW5pZXMs IGFjYWRlbW ljIGluc3Rp dHV0aW9ucy wgYW5kIGdv dmVybm1lbn QgYWdlbmNp ZXMgdG8gYW NjZWxlcmF0 ZSBpbm5vdm F0aW9uIGFu ZCBicmluZy BuZXcgdHJl YXRtZW50cy B0byBtYXJr ZXQuIFRoZX NlIGNvbGxh Ym9yYXRpb2 5zIGVuaGFu Y2UgdGhlIG NvbXBhbnkn cyByZXNlYX JjaCBjYXBh YmlsaXRpZX MgYW5kIGV4 cGFuZCBpdH MgcmVhY2gg aW4gdGhlIG dsb2JhbCBo ZWFsdGhjYX JlIG1hcmtl dC4=
What the company's business model?
Pfizer

πŸ“ˆ Want to read more about Pfizer?

Sign up for free or log in

✍️ Sign up to get "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" for free

UGZpemVyIG lzIGEgbXVs dGluYXRpb2 5hbCBwaGFy bWFjZXV0aW NhbCBjb21w YW55IHdpdG ggYSBidXNp bmVzcyBtb2 RlbCBiYXNl ZCBvbiByZX NlYXJjaCwg ZGV2ZWxvcG 1lbnQsIHBy b2R1Y3Rpb2 4sIGFuZCBt YXJrZXRpbm cgb2YgaW5u b3ZhdGl2ZS BhbmQgZ2Vu ZXJpYyBwcm VzY3JpcHRp b24gZHJ1Z3 MsIHZhY2Np bmVzLCBhbm QgY29uc3Vt ZXIgaGVhbH RoY2FyZSBw cm9kdWN0cy 4gSXRzIGJ1 c2luZXNzIG 9wZXJhdGlv bnMgYXJlIH NlZ21lbnRl ZCBpbnRvIH RocmVlIG1h aW4gYXJlYX M6IElubm92 YXRpdmUgSG VhbHRoLCBF c3NlbnRpYW wgSGVhbHRo LCBhbmQgQ2 9uc3VtZXIg SGVhbHRoY2 FyZS48YnI+ VGhlIElubm 92YXRpdmUg SGVhbHRoIH NlZ21lbnQg Zm9jdXNlcy BvbiBkZXZl bG9waW5nIG FuZCBjb21t ZXJjaWFsaX ppbmcgbmV3 IG1lZGljaW 5lcyBpbiBh cmVhcyBzdW NoIGFzIG9u Y29sb2d5LC BpbmZsYW1t YXRpb24gYW 5kIGltbXVu b2xvZ3ksIH JhcmUgZGlz ZWFzZXMsIG FuZCB2YWNj aW5lcy4gVG hpcyBpbmNs dWRlcyBpbn Zlc3Rpbmcg aW4gcmVzZW FyY2ggYW5k IGRldmVsb3 BtZW50IHRv IGRpc2Nvdm VyIG5ldyB0 cmVhdG1lbn RzLCBvYnRh aW5pbmcgcm VndWxhdG9y eSBhcHByb3 ZhbCwgYW5k IG1hcmtldG luZyBhbmQg c2VsbGluZy B0aGVtIHdv cmxkd2lkZS 48YnI+VGhl IEVzc2VudG lhbCBIZWFs dGggc2VnbW VudCBwcmlt YXJpbHkgZm 9jdXNlcyBv biB0aGUgcH JvZHVjdGlv biBhbmQgc2 FsZSBvZiBl c3RhYmxpc2 hlZCBnZW5l cmljIG1lZG ljaW5lcywg YXMgd2VsbC BhcyBiaW9z aW1pbGFycy 4gVGhlc2Ug YXJlIGxvd2 VyLWNvc3Qg YWx0ZXJuYX RpdmVzIHRv IGJyYW5kZW QgZHJ1Z3Mg YW5kIGFyZS BwcmltYXJp bHkgdXNlZC B0byB0cmVh dCBjb21tb2 4gY29uZGl0 aW9ucyBzdW NoIGFzIGh5 cGVydGVuc2 lvbiBhbmQg ZGlhYmV0ZX MuPGJyPlRo ZSBDb25zdW 1lciBIZWFs dGhjYXJlIH NlZ21lbnQg aW5jbHVkZX Mgb3Zlci10 aGUtY291bn RlciAoT1RD KSBwcm9kdW N0cyBzdWNo IGFzIG51dH JpdGlvbmFs IHN1cHBsZW 1lbnRzLCBw YWluIHJlbG lldmVycywg YW5kIHBlcn NvbmFsIGNh cmUgaXRlbX MuIFRoZXNl IHByb2R1Y3 RzIGFyZSBz b2xkIGRpcm VjdGx5IHRv IGNvbnN1bW VycyB3aXRo b3V0IGEgcH Jlc2NyaXB0 aW9uIGFuZC BhcmUgd2lk ZWx5IGF2YW lsYWJsZSBp biByZXRhaW wgc3RvcmVz Ljxicj5QZm l6ZXIncyBi dXNpbmVzcy Btb2RlbCBh bHNvIGluY2 x1ZGVzIHN0 cmF0ZWdpYy BwYXJ0bmVy c2hpcHMgYW 5kIGNvbGxh Ym9yYXRpb2 5zIHdpdGgg b3RoZXIgcG hhcm1hY2V1 dGljYWwgY2 9tcGFuaWVz LCBhY2FkZW 1pYyBpbnN0 aXR1dGlvbn MsIGFuZCBn b3Zlcm5tZW 50IG9yZ2Fu aXphdGlvbn MgdG8gZnVy dGhlciBlbm hhbmNlIHRo ZWlyIHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudCBl ZmZvcnRzLj xicj5PdmVy YWxsLCBQZm l6ZXIncyBi dXNpbmVzcy Btb2RlbCBp cyBjZW50ZX JlZCBvbiBp bm5vdmF0aW 9uLCBtYXJr ZXQgZXhwYW 5zaW9uLCBh bmQgY29sbG Fib3JhdGlv biB0byBwcm 92aWRlIGEg ZGl2ZXJzZS Bwb3J0Zm9s aW8gb2YgcH JvZHVjdHMg dGhhdCBpbX Byb3ZlIHRo ZSBoZWFsdG ggYW5kIHdl bGwtYmVpbm cgb2YgcGVv cGxlIGFyb3 VuZCB0aGUg d29ybGQu
Is AI a threat?
AI does pose certain risks to Pfizer’s products, services, and competitive positioning, although the extent of these threats may vary.
1. Substitution: AI-driven pharmaceutical technologies could lead to the development of alternative therapies or treatments that may circumvent traditional pharmaceutical approaches. For instance, AI can optimize drug discovery and development processes, potentially leading to faster and more cost-effective treatments that challenge Pfizer’s existing product lines. Advances in biotechnology, including gene editing and personalized medicine facilitated by AI, could produce therapies that compete directly with Pfizer’s offerings.
2. Disintermediation: AI has the potential to streamline healthcare delivery, which might reduce the need for intermediaries, such as healthcare providers or pharmaceutical sales representatives. For example, telemedicine platforms powered by AI could lower barriers to accessing medications, allowing patients to obtain treatments through direct-to-consumer models. This shift could disrupt Pfizer’s traditional distribution channels and market strategies.
3. Margin Pressure: The increasing use of AI can lead to more efficient drug development processes, potentially lowering the cost of bringing new drugs to market. While this could result in lower prices for consumers, it may also put pressure on Pfizer’s profit margins. If competitors leverage AI effectively to reduce costs, Pfizer might face challenges in maintaining pricing power for its products.
Overall, while AI presents opportunities for innovation and efficiency, it also introduces competitive pressures that could impact Pfizer’s market positioning and profitability. The company would need to adapt by investing in AI technologies and developing strategies to mitigate these risks.
Sensitivity to interest rates
The sensitivity of Pfizer’s earnings, cash flow, and valuation to changes in interest rates can be analyzed through several key factors:
1. Earnings Sensitivity: Changes in interest rates can affect Pfizer’s earnings primarily through their impact on the cost of borrowing and investment decisions. If interest rates rise, the cost of financing existing debt may increase, potentially reducing net income. Additionally, higher rates could lead to decreased consumer spending and healthcare investment, which might lower demand for Pfizer’s products, particularly in noessential categories.
2. Cash Flow Sensitivity: Pfizer’s cash flow can also be sensitive to interest rate changes. Higher interest rates can result in increased interest expenses, which would decrease operating cash flow. Additionally, an environment of rising rates may slow down economic growth, potentially impacting sales and, subsequently, cash flows from operations. Conversely, if rates decrease, Pfizer might benefit from lower borrowing costs, enhancing cash flow.
3. Valuation Sensitivity: The valuation of Pfizer, often assessed through discounted cash flow (DCF) models, is significantly affected by interest rates. Higher interest rates increase the discount rate used to calculate the present value of future cash flows, typically resulting in a lower valuation. In contrast, lower rates would decrease the discount rate and could potentially enhance valuation. Moreover, shifts in interest rates can impact investor sentiment and risk perception, which can also influence stock price movements.
4. Market Conditions: The broader market can amplify Pfizer’s sensitivity to interest rate changes. For instance, when rates rise, it might lead to a rotation out of growth stocks, affecting valuation multiples. Changes in interest rates may also influence regulatory and reimbursement environments, further affecting Pfizer’s business dynamics.
In summary, Pfizer’s earnings, cash flow, and valuation are notably sensitive to changes in interest rates due to their impact on borrowing costs, consumer demand, and overall economic conditions. Each increase or decrease in rates can have downstream effects that may influence the company’s financial health and market perception.
Resilience to the future changes
Pfizer

πŸ“ˆ Want to read more about Pfizer?

Sign up for free or log in

βœ… Download "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” totally free!

QSByZWFsaX N0aWMgc2Nl bmFyaW8gdG hhdCBjb3Vs ZCBwZXJtYW 5lbnRseSBp bXBhaXIgUG ZpemVy4oCZ cyBlY29ub2 1pY3Mgb3Zl ciB0aGUgbm V4dCAz4oCT NSB5ZWFycy BpcyB0aGUg ZmFpbHVyZS BvZiBpdHMg a2V5IHByb2 R1Y3RzLCBw YXJ0aWN1bG FybHkgaXRz IHZhY2Npbm VzIGFuZCB0 aGVyYXBldX RpY3MsIHRv IGFjaGlldm Ugc3VzdGFp bmVkIGRlbW FuZCBhbmQg cmV2ZW51ZS BkdWUgdG8g ZW1lcmdpbm cgY29tcGV0 aXRpb24sIH BhdGVudCBl eHBpcmF0aW 9ucywgb3Ig c2lnbmlmaW NhbnQgcHVi bGljIGhlYW x0aCBjaGFu Z2VzLjxicj 5JZiBhIG5l dywgbW9yZS BlZmZlY3Rp dmUgdHJlYX RtZW50IG9y IHZhY2Npbm Ugd2VyZSB0 byBlbWVyZ2 UgZm9yIENP VklELTE5IG 9yIG90aGVy IHByZXZhbG VudCBkaXNl YXNlcyBmb3 Igd2hpY2gg UGZpemVyIG N1cnJlbnRs eSBob2xkcy BhIGxlYWRp bmcgbWFya2 V0IHBvc2l0 aW9uLCB0aG lzIGNvdWxk IGxlYWQgdG 8gYSBzaGFy cCBkZWNsaW 5lIGluIHNh bGVzIG9mIG l0cyBleGlz dGluZyBwcm 9kdWN0cy4g QWRkaXRpb2 5hbGx5LCBp ZiBrZXkgcG F0ZW50cyB3 ZXJlIHRvIG V4cGlyZSB3 aXRob3V0IH N1ZmZpY2ll bnQgcmVwbG FjZW1lbnQg cHJvZHVjdH MgaW4gdGhl IHBpcGVsaW 5lLCBQZml6 ZXIgY291bG Qgc2VlIGEg ZHJhbWF0aW MgZHJvcCBp biByZXZlbn VlLjxicj5J biB0aGlzIH NjZW5hcmlv LCBQZml6ZX LigJlzIG1h cmdpbnMgY2 91bGQgc3Vm ZmVyIGFzIH RoZSBjb21w YW55IHdvdW xkIG5lZWQg dG8gZW5nYW dlIGluIHBy aWNlIGNvbX BldGl0aW9u IHRvIHJldG FpbiBtYXJr ZXQgc2hhcm UuIEZpeGVk IGNvc3RzIH JlbGF0ZWQg dG8gUiZhbX A7RCBhbmQg bWFudWZhY3 R1cmluZyB3 b3VsZCByZW 1haW4gaGln aCwgYnV0IH JldmVudWVz IHdvdWxkIG RlY2xpbmUs IGxlYWRpbm cgdG8gYSBw b3RlbnRpYW wgc3F1ZWV6 ZSBvbiBwcm 9maXQgbWFy Z2lucy4gPG JyPkNhc2gg ZmxvdyBtaW dodCBhbHNv IHR1cm4gbm VnYXRpdmUg aWYgdGhlIG RlY2xpbmUg aW4gcmV2ZW 51ZSBpcyBz dGVlcCBhbm QgcGVyc2lz dGVudC4gU3 VzdGFpbmVk IHJlZHVjdG lvbnMgaW4g c2FsZXMgY2 91bGQgZm9y Y2UgUGZpem VyIHRvIGN1 dCBiYWNrIG 9uIGV4cGVu c2VzLCBpbm NsdWRpbmcg UiZhbXA7RC BpbnZlc3Rt ZW50cyB0aG F0IGFyZSBj cnVjaWFsIG ZvciBmdXR1 cmUgZ3Jvd3 RoLiBUaGlz IHdvdWxkIG hhbXBlciBp dHMgYWJpbG l0eSB0byBp bm5vdmF0ZS BhbmQgYnJp bmcgbmV3IH Byb2R1Y3Rz IHRvIG1hcm tldCwgcmVz dWx0aW5nIG luIGEgdmlj aW91cyBjeW NsZSB0aGF0 IGNvdWxkIG Z1cnRoZXIg aW1wYWlyIG l0cyBsb25n LXRlcm0gY2 9tcGV0aXRp dmVuZXNzLj xicj5PbiB0 aGUgYmFsYW 5jZSBzaGVl dCwgUGZpem VyIGNvdWxk IHNlZSBhbi BpbmNyZWFz ZSBpbiBkZW J0IGlmIGl0 IHRvb2sgb2 4gYWRkaXRp b25hbCBmaW 5hbmNpbmcg dG8gbWFuYW dlIGNhc2gg ZmxvdyBpc3 N1ZXMuIEEg ZGV0ZXJpb3 JhdGlvbiBp biBjYXNoIH Jlc2VydmVz LCBjb3VwbG VkIHdpdGgg ZGVjbGluaW 5nIHJldmVu dWVzLCB3b3 VsZCByYWlz ZSBjb25jZX JucyBhbW9u ZyBpbnZlc3 RvcnMgYWJv dXQgdGhlIG NvbXBhbnni gJlzIGZpbm FuY2lhbCBz dGFiaWxpdH kuIFRoaXMg Y291bGQgbG VhZCB0byBh IGxvd2VyIG NyZWRpdCBy YXRpbmcsIG Z1cnRoZXIg aW5jcmVhc2 luZyBib3Jy b3dpbmcgY2 9zdHMgYW5k IGV4YWNlcm JhdGluZyB0 aGUgZmluYW 5jaWFsIHN0 cmFpbi48Yn I+SW4gc3Vt bWFyeSwgaW YgUGZpemVy IGV4cGVyaW VuY2VkIGEg c2lnbmlmaW NhbnQgYW5k IHN1c3RhaW 5lZCBkcm9w IGluIHJldm VudWUgZHVl IHRvIGNvbX BldGl0aXZl IHByZXNzdX JlcyBvciBw YXRlbnQgY2 hhbGxlbmdl cywgaXQgY2 91bGQgbGVh ZCB0byBjb2 1wcmVzc2Vk IG1hcmdpbn MsIG5lZ2F0 aXZlIGNhc2 ggZmxvdywg YW5kIGEgd2 Vha2VuZWQg YmFsYW5jZS BzaGVldCBj aGFyYWN0ZX JpemVkIGJ5 IGluY3JlYX NlZCBkZWJ0 IGFuZCBsb3 dlciBsaXF1 aWRpdHkuIF N1Y2ggZGV2 ZWxvcG1lbn RzIHdvdWxk IGZ1bmRhbW VudGFsbHkg YWx0ZXIgdG hlIGNvbXBh bnnigJlzIG ZpbmFuY2lh bCBoZWFsdG ggYW5kIGxv bmctdGVybS B2aWFiaWxp dHkuPGJyPg ==
Interesting facts about the company
Pfizer

πŸ“ˆ Want to read more about Pfizer?

Sign up for free or log in

πŸš€ Don’t miss "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvR0 5XR3NZUk52 aVNJZlhrZm pHamcud2Vi cCIgYWx0PS JQZml6ZXIi IHRpdGxlPS JQZml6ZXIi ICBjbGFzcz 0iaW1nLWZs dWlkIiBoZW lnaHQ9NTAg d2lkdGg9NT AgbG9hZGlu Zz0nbGF6eS cgc3R5bGU9 J2JvcmRlci 1yYWRpdXM6 IDZweDsnPg oKICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdmbGV4 OiAxOyB0ZX h0LWFsaWdu OiBjZW50ZX I7IG1hcmdp bi1sZWZ0Oi A1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPHAgc3R5 bGU9J2Zvbn Qtc2l6ZTog MjZweDsgY2 9sb3I6ICMz MzM7IG1hcm dpbi1ib3R0 b206IDE1cH g7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfk4gg V2FudCB0by ByZWFkIG1v cmUgYWJvdX QgUGZpemVy PwogICAgIC AgICAgICAg ICAgICAgIC AgICA8L3A+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8YSBo cmVmPSdpbm RleC5waHA/ cGFnZT1zaW dudXAnIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGJhY2 tncm91bmQt Y29sb3I6IC MwMDdCRkY7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBj b2xvcjogI2 ZmZjsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH ggMjBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGJv cmRlci1yYW RpdXM6IDVw eDsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IHRleHQtZG Vjb3JhdGlv bjogbm9uZT sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG ZvbnQtd2Vp Z2h0OiBib2 xkOwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgbWFyZ2lu LXJpZ2h0Oi AxMHB4Owog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgdHJh bnNpdGlvbj ogYmFja2dy b3VuZC1jb2 xvciAwLjNz IGVhc2U7Jw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgb2 5tb3VzZW92 ZXI9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA1Nm IzIicKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG9ubW91 c2VvdXQ9J3 RoaXMuc3R5 bGUuYmFja2 dyb3VuZENv bG9yPSIjMD A3QkZGIic+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBT aWduIHVwIG ZvciBmcmVl CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvYT4K CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxzcGFu IHN0eWxlPS dtYXJnaW46 IDAgOHB4Oy Bjb2xvcjog IzU1NTsnPm 9yPC9zcGFu PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9bG 9naW4nIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGNvbG 9yOiAjMDA3 QkZGOwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgdGV4dC 1kZWNvcmF0 aW9uOiB1bm RlcmxpbmU7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBm b250LXdlaW dodDogNTAw Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBsb2cgaW 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9hPg oKCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxwIH N0eWxlPSdt YXJnaW4tdG 9wOiAxNXB4 OyBmb250LX NpemU6IDEz cHg7IGZvbn Qtd2VpZ2h0 OiBib2xkOy Bjb2xvcjog I2QzMmYyZj snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Ag8J+TmiBZ b3VyIGZyZW UgY29weSBv ZiA8aT4iVG hlIENoZWNr bGlzdCBWYW x1ZSBJbnZl c3RvciDigJ QgQSBTbWFy dGVyIFdheS B0byBQaWNr IFN0b2Nrcy I8L2k+IGlz IHdhaXRpbm cKICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9wPg oKICAgICAg ICAgICAgIC AgICAgICAg ICAgPCEtLQ ogICAgICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdt YXJnaW4tdG 9wOiAxMnB4 OyBmb250LX NpemU6IDEz cHg7IGNvbG 9yOiAjNDQ0 Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBTaWduIH VwIG5vdyBh bmQgZ2V0IG 91ciBmcmVl IGVCb29rIA ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgPG I+VGhlIENo ZWNrbGlzdC BWYWx1ZSBJ bnZlc3Rvci DigJQgQSBT bWFydGVyIF dheSB0byBQ aWNrIFN0b2 NrczwvYj4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9kaXY+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIC0tPgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8IS0tCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xkaXYgc3R5 bGU9J21hcm dpbi10b3A6 IDE2cHg7IG ZvbnQtc2l6 ZTogMTRweD sgY29sb3I6 ICM0NDQ7IG ZvbnQtZmFt aWx5OiAtYX BwbGUtc3lz dGVtLCBCbG lua01hY1N5 c3RlbUZvbn QsIFNlZ29l IFVJLCBSb2 JvdG8sIEhl bHZldGljYS BOZXVlLCBz YW5zLXNlcm lmOyBsaW5l LWhlaWdodD ogMS42Oyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBI YXZlIHlvdS BoZWFyZCBh Ym91dCBvdX Igc2hvcnQg PHN0cm9uZy BzdHlsZT0n Zm9udC13ZW lnaHQ6IDYw MDsnPkRhaW x5IFZpZGVv IE5ld3NsZX R0ZXI8L3N0 cm9uZz4/Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICA8YS BocmVmPSdo dHRwczovL3 d3dy5pbnNp Z2h0ZnVsdm FsdWUuY29t L25ld3NsZX R0ZXIucGhw JyB0YXJnZX Q9J19ibGFu aycgc3R5bG U9J2NvbG9y OiAjMDA3Qk ZGOyB0ZXh0 LWRlY29yYX Rpb246IG5v bmU7IGZvbn Qtd2VpZ2h0 OiA1MDA7IG 1hcmdpbi1s ZWZ0OiA2cH g7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBG aW5kIG91dC Btb3JlCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvZGl2 PgogICAgIC AgICAgICAg ICAgICAgIC AgICAtLT4K ICAgICAgIC AgICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgICAgIDwv ZGl2PgogIC AgICAgICAg ICA8L2Rpdj 4KICAgICAg ICAgICAgCi AgICAgICAg CiAgICAgIC AgPHNwYW4g Y2xhc3M9J2 JsdXJyZWQt dGV4dCc+Ci AgICAgICAg ICAgIE1TNG dVR1pwZW0g VnlJSGRoY3 lCbSBiM1Z1 WkdWa0lHIG x1SURFNE5E a2cgWW5rZ2 RIZHZJRyBO dmRYTnBibk 1zIElFTm9Z WEpzWlggTW dVR1pwZW1W eSBJR0Z1Wk NCRGFHIEZ5 YkdWeklFVn kgYUdGeWRD d2dhVyA0Z1 FuSnZiMnRz IGVXNHNJRT VsZHkgQlpi M0pyTGlCVS BhR1VnWTI5 dGNHIEZ1ZV NCcGJtbDAg YVdGc2JIa2 djSCBKdlpI VmpaV1FnIF kybDBjbWxq SUcgRmphV1 FzSUdGdSBJ R0ZzWTI5b2 IyIHd0WW1G elpXUWcgWV c1MGFYTmxj SCBScFl5d2 dZVzVrIElH eGhkR1Z5SU cgVjRjR0Z1 WkdWayBJSF J2SUhCeWIy IFIxWTJVZ2 IzUm8gWlhJ Z1kyaGxiVy BsallXeHpJ R0Z1IFpDQn dhR0Z5Ylcg RmpaWFYwYV dOaCBiSE11 UEdKeVBqIE l1SUVsdUlE RTUgTlRBc0 lGQm1hWCBw bGNpQnlaWF p2IGJIVjBh Vzl1YVggcG xaQ0IwYUdV ZyBjR2hoY2 0xaFkyIFYx ZEdsallXd2 cgYVc1a2RY TjBjbiBrZ2 QybDBhQ0Iw IGFHVWdaR2 x6WTIgOTJa WEo1SUc5bS BJRlJsY25K aGJYIGxqYV c0c0lIUm8g WlNCbWFYSn pkQyBCaWNt OWhaQzF6IG NHVmpkSEox YlMgQmhibl JwWW1sdiBk R2xqTGlCVW FHIGx6SUdS cGMyTnYgZG 1WeWVTQnNa VyBRZ2RHOG dkR2hsIElH RnVkR2xpYV cgOTBhV01n Y21WMiBiMn gxZEdsdmJp IHdnYzJGMm FXNW4gSUdO dmRXNTBiRy BWemN5QnNh WFpsIGN5Qm hibVFnYVcg MXdjbTkyYV c1biBJR2hs WVd4MGFHIE 5oY21VZ1lY SnYgZFc1a0 lIUm9aUyBC M2IzSnNaQz Q4IFluSStN eTRnVkcgaG xJR0pzZFdV ZyBjR2xzYk N3Z1ZtIGxo WjNKaExDQj MgWVhNZ2FX NTBjbSA5a2 RXTmxaQ0Jp IGVTQlFabW w2WlggSWdh VzRnTVRrNS BPQ0JoYm1R Z2NYIFZwWT J0c2VTQmkg WldOaGJXVW diMiA1bElH OW1JSFJvIF pTQnRiM04w SUggTjFZMk 5sYzNObSBk V3dnYldWa2 FXIE5oZEds dmJuTWcgYV c0Z2FHbHpk RyA5eWVTNG dTWFFnIGQy RnpJSFJvWl MgQm1hWEp6 ZENCdiBjbU ZzSUcxbFpH IGxqWVhScG IyNGcgWm05 eUlIUm9aUy BCMGNtVmhk RzFsIGJuUW diMllnWlgg SmxZM1JwYk dVZyBaSGx6 Wm5WdVkzIF JwYjI0Z1lX NWsgSUdoaG N5QmlaVyBW dUlIVnpaV1 FnIFlua2di V2xzYkcgbH Zibk1nYjJZ ZyBiV1Z1SU hkdmNtIHhr ZDJsa1pTND ggWW5JK05D NGdVRyBacG VtVnlJR2x6 IElHOXVaU0 J2WmkgQjBh R1VnYkdGeS BaMlZ6ZENC d2FHIEZ5Yl dGalpYVjAg YVdOaGJDQm piMiAxd1lX NXBaWE1nIG FXNGdkR2hs SUggZHZjbX hrTENCMyBh WFJvSUc5d1 pYIEpoZEds dmJuTWcgYV c0Z2IzWmxj aSBBeE1qVW dZMjkxIGJu UnlhV1Z6SU cgRnVaQ0Iw WlhKeSBhWF J2Y21sbGN5 IDRnU1hRZ1 pXMXcgYkc5 NWN5QnZkbS BWeUlEa3dM REF3IE1DQn daVzl3Ykcg VWdZVzVrSU doaCBjeUJo SUhKbGRtIF Z1ZFdVZ2Iy WWcgYjNabG NpQWtOVCBB Z1ltbHNiR2 x2IGJpNDhZ bkkrTlMgNG dWR2hsSUdO diBiWEJoYm 5rZ2FYIE1n WTI5dGJXbD AgZEdWa0lI UnZJRyBkc2 IySmhiQ0Jv IFpXRnNkR2 dnWVcgNWtJ R2hoY3lCdC BZV1JsSUhO cFoyIDVwWm 1sallXNTAg SUdOdmJuUn lhVyBKMWRH bHZibk1nIG RHOGdaR2x6 WlcgRnpaU0 JsY21GayBh V05oZEdsdm JpIEJoYm1R Z1kyOXUgZE hKdmJDQndj bSA5bmNtRn RjeTRnIFNX NGdNVGs1T0 Mgd2dVR1pw ZW1WeSBJR1 J2Ym1GMFpX IFFnTWpBd0 lHMXAgYkd4 cGIyNGdaRy A5elpYTWdi MllnIGRHaG xJR0Z1ZEcg bGlhVzkwYV dNZyBXbWww YUhKdmJXIE Y0SUhSdklH WnAgWjJoME lIUnlZVyBO b2IyMWhMQ0 JoIElHSnNh VzVrYVcgNW 5JR1Y1WlNC cCBibVpsWT NScGIyIDR1 UEdKeVBqWX UgSUZCbWFY cGxjaSBCcG N5QnJibTkz IGJpQm1iM0 lnYVggUnpJ SE4wY205dS BaeUJ5WlhO bFlYIEpqYU NCaGJtUWcg WkdWMlpXeH ZjRyAxbGJu UWdZMkZ3IF lXSnBiR2ww YVcgVnpMQ0 JwYm5abCBj M1JwYm1jZ2 IzIFpsY2lB a09DQmkgYV d4c2FXOXVJ RyBWaFkyZ2 dlV1ZoIGNp QnBiaUJ5Wl ggTmxZWEpq YUNCaCBibV FnWkdWMlpX IHh2Y0cxbG JuUXUgSUVs MElHaGhjeS BCdmRtVnlJ RFl3IE1DQn ZibWR2YVcg NW5JSEpsYz JWaCBjbU5v SUhCeWIyIH BsWTNSeklH RmogY205em N5QjJZWCBK cGIzVnpJR1 JwIGMyVmhj MlVnWVggSm xZWE11UEdK eSBQamN1SU ZCbWFYIHBs Y2lCb1lYTW cgWVNCc2Iy NW5JRyBocG MzUnZjbmtn IGIyWWdiV0 Z1ZFcgWmhZ M1IxY21sdS BaeUIyWVdO amFXIDVsY3 l3Z2FXNWog YkhWa2FXNW 5JSCBSb1pT QjJZV05qIG FXNWxJR1p2 Y2kgQndibV YxYlc5aiBi Mk5qWVd3Z1 pHIGx6WldG elpTd2cgYl dWdWFXNW5i MiBOdlkyTm hiQ0JrIGFY TmxZWE5sTE MgQmhibVFn WTJocCBZMn RsYm5CdmVD IDRnU1c0Z0 1qQXkgTUN3 Z2RHaGxJRy BOdmJYQmhi bmtnIFpHVj JaV3h2Y0cg VmtJRzl1Wl NCdiBaaUIw YUdVZ1ptIG x5YzNRZ1Ew OVcgU1VRdE 1Ua2dkbSBG alkybHVaWE 1nIGFXNGdj R0Z5ZEcgNW xjbk5vYVhB ZyBkMmwwYU NCQ2FXIDlP VkdWamFDd2 cgZDJocFky Z2dhWCBNZ1 ltVnBibWNn IGRYTmxaQ0 IzYjMgSnNa SGRwWkdVdS BQR0p5UGpn dUlGIFJvWl NCamIyMXcg WVc1NUlHaG hjeSBCaElH UnBkbVZ5IG MyVWdjRzl5 ZEcgWnZiR2 x2SUc5bSBJ SEJ5YjJSMV kzIFJ6TENC cGJtTnMgZF dScGJtY2dj SCBKbGMyTn lhWEIwIGFX OXVJRzFsWk cgbGphVzVs Y3l3ZyBkbU ZqWTJsdVpY IE1zSUdGdV pDQmogYjI1 emRXMWxjaS BCb1pXRnNk R2hqIFlYSm xJSEJ5YjIg UjFZM1J6TG lCVCBiMjFs SUc5bUlHIG wwY3lCM1pX eHMgTFd0dW IzZHVJRyBK eVlXNWtjeU JwIGJtTnNk V1JsSUUgeH BjR2wwYjNJ cyBJRU5sYk dWaWNtIFY0 TENCaGJtUW cgUVdSMmFX d3VQRyBKeV Bqa3VJRkJt IGFYcGxjaU JvWVggTWdZ U0J6ZEhKdi BibWNnWTI5 dGJXIGwwYl dWdWRDQjAg YnlCemRYTj BZVyBsdVlX SnBiR2wwIG VTQmhibVFn YUcgRnpJSE 5sZENCaCBi V0pwZEdsdm RYIE1nWjI5 aGJITWcgZE c4Z2NtVmtk VyBObElHbD BjeUJsIGJu WnBjbTl1Yl cgVnVkR0Zz SUdsdCBjR0 ZqZEM0Z1NY IFFnYUdGek lIQnMgWldS blpXUWdkRy A4Z2NtVmtk V05sIElHbD BjeUJuY20g VmxibWh2ZF hObCBJR2Ro Y3lCbGJXIG x6YzJsdmJu TXMgSUhkaG RHVnlJSCBW ellXZGxMQ0 JoIGJtUWdk MkZ6ZEcgVW daMlZ1WlhK aCBkR2x2Ym lCaWVTIEF5 TUNVZ1lua2 cgTWpBeU5T NDhZbiBJK0 1UQXVJRWx1 IElESXdNak FzSUYgQm1h WHBsY2lCMy BZWE1nYm1G dFpXIFFnYj I1bElHOW0g SUhSb1pTQj NiMyBKc1pP S0FtWE1nIG JXOXpkQ0Jo WkcgMXBjbV ZrSUdOdiBi WEJoYm1sbG N5IEJpZVNC R2IzSjAgZF c1bElFMWha MiBGNmFXNW xMQ0J5IFlX NXJhVzVuSU cgWnBjbk4w SUdsdSBJSF JvWlNCd2FH IEZ5YldGal pYVjAgYVdO aGJDQnBibS BSMWMzUnll UzRnIFNYUW dhR0Z6SUcg RnNjMjhnWW 1WbCBiaUJ5 WldOdloyID VwZW1Wa0lH WnYgY2lCcG RITWdaRyBs MlpYSnphWF I1IElHRnVa Q0JwYm0gTn NkWE5wYjI0 ZyBaV1ptYj NKMGN5IHdn WldGeWJtbH UgWnlCaElI TndiMyBRZ2 IyNGdkR2hs IElESXdNak VnUkcgbDJa WEp6YVhSNS BTVzVqSUZS dmNDIEExTU NCRGIyMXcg WVc1cFpYTW dabSA5eUlF UnBkbVZ5IG MybDBlU0Jz YVggTjBMZz 09CiAgICAg ICAgPC9zcG FuPgogICAg ICAgIAogIC AgICAgIA==
See Company Q&A
Pfizer

πŸ“Š Get full analytics about Pfizer

Sign up for free or log in

πŸ”“ Unlock our free guide: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

© 2024 - 2026 InsightfulValue.com. All rights reserved. Newsletter
Legal